アルファエミッターの世界市場レポート 2025

アルファエミッター市場規模は、今後数年で飛躍的な成長が見込まれます。2029年には年間平均成長率（CAGR）23.4%で37億3,000万米ドルに成長します。予測期間の成長は、医療費の増加、心疾患患者の増加、併用療法の増加、標的α療法の普及、研究開発活動の活発化などに起因しています。予測期間における主な動向としては、イメージング技術の進歩、製品の革新、戦略的提携、放射性医薬品開発の進歩、新しいアルファ線放出同位元素の開発などが挙げられます。

がん罹患率の上昇が、今後のアルファエミッター市場の成長を牽引すると予測されます。がんは、制御不能な異常細胞の増殖と拡散によって特徴づけられる疾患であり、腫瘍を形成して近隣の組織に浸潤する可能性があります。がんが蔓延する要因としては、人口の高齢化、環境暴露、ライフスタイルの変化、検出方法の改善などが挙げられます。アルファ線放出装置は、周囲の健康な組織への害を最小限に抑えながら、腫瘍細胞を高い精度で標的にして破壊するために、がん治療に利用されています。例えば、2023年8月、オーストラリア政府の保健行政機関であるオーストラリア保健福祉研究所は、がんと診断されるアメリカ人の数（皮膚の基底細胞がんと扁平上皮がんを除く）が、2021年の15万1,000人から2030年には18万5,000人に増加すると予測しました。その結果、がんの有病率の増加がアルファエミッター市場の成長に拍車をかけています。

アルファ放出核種市場の主要企業は、サイクロトロンを用いて製造されるアルファ放出核種などの革新的ソリューションへの投資に注力し、競争優位を獲得しようとしています。これらの放射性核種は、崩壊時にアルファ粒子を放出する放射性同位体であり、サイクロトロンで荷電粒子を高エネルギーまで加速することで生成されます。例えば、2023年4月、米国のサイクロトロン・テクノロジー企業であるIonetix社は、ミシガン州ランシングに新設したアルファアイソトープ製造施設で、同社初のアルファ放出核種であるアスタチン211（At-211）を製造しました。この施設は、サイクロトロン技術によるアルファ放出核種の製造に特化した米国初の施設として注目されています。この製造は、At-211とアクチニウム-225（Ac-225）を高収率で製造するためにアルファ粒子を加速するように設計された30MeVサイクロトロンの試運転によって可能となりました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アルファエミッターPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアルファエミッター市場：成長率分析
• 世界のアルファエミッター市場の実績：規模と成長, 2019-2024
• 世界のアルファエミッター市場の予測：規模と成長, 2024-2029, 2034F
• 世界アルファエミッター総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアルファエミッター市場放射性核種の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラジウム
• アクチニウム
• 鉛
• ビスマス
• その他の種類の放射性核種
• 世界のアルファエミッター市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然資源
• 人工的に生成されたソース
• その他の情報源
• 世界のアルファエミッター市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 膵臓がん
• 卵巣がん
• 前立腺がん
• リンパ腫
• 黒色腫
• 骨転移
• その他の用途
• 世界のアルファエミッター市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医療調査機関
• その他のエンドユーザー
• 世界のアルファエミッター市場ラジウムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラジウム223
• ラジウム226
• ラジウム228
• 世界のアルファエミッター市場アクチニウムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アクチニウム227
• アクチニウム225
• 世界のアルファエミッター市場リードのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鉛-210
• 鉛-212
• 世界のアルファエミッター市場ビスマスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビスマス213
• ビスマス212
• 世界のアルファエミッター市場、その他の種類の放射性核種のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• トリウム
• ポロニウム
• フランシウム

第7章 地域別・国別分析

• 世界のアルファエミッター市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアルファエミッター市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アルファエミッター市場：競合情勢
• アルファエミッター市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Telix Pharmaceuticals Limited
• NorthStar Medical Radioisotopes LLC
• ITM Isotope Technologies Munich SE
• Blue Earth Diagnostics Ltd.
• International Isotopes Inc.
• IBA Radiopharma Solutions
• Orano Med LLC
• ARTbio AS
• Actinium Pharmaceuticals Inc.
• Clarity Pharmaceuticals Ltd.
• RadioMedix Inc.
• Nordic Nanovector ASA
• Convergent Therapeutics
• TAE Life Sciences
• ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アルファエミッター市場2029：新たな機会を提供する国
• アルファエミッター市場2029：新たな機会を提供するセグメント
• アルファエミッター市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An alpha emitter is a type of radioactive substance that releases alpha particles during radioactive decay. It includes elements, such as uranium, radium, and plutonium, that undergo alpha decay as part of their natural radioactive processes. Alpha emitters play a significant role in medical treatments, especially cancer therapy, and in various technological applications such as smoke detectors and space exploration.

The main types of radionuclide of alpha emitters are radium, actinium, lead, bismuth, and others. Radium is a radioactive element used in medical treatments and diagnostic procedures. The source is natural sources, artificially produced sources, and others, and applications are pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. It is used by various end-users such as hospitals, medical research institutions, and others.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.3 $ billion in 2024 to $1.61 $ billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increasing incidence of cancer, growing research investments, government support and funding, rising aging population, and expansion of radiotherapy centers.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $3.73 $ billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to rising medical expenditure, the growing number of patients with cardiac ailments, growing use of combination therapies, the increasing prevalence of targeted alpha therapy, and increasing research and development activities. Major trends in the forecast period include advancements in imaging technologies, product innovations, strategic collaboration, advancements in radiopharmaceutical development, and development of new alpha-emitting isotopes.

The rising prevalence of cancer is anticipated to drive the growth of the alpha emitter market in the future. Cancer is a disease marked by the uncontrolled proliferation and spread of abnormal cells, which can form tumors and invade nearby tissues. Contributing factors to cancer prevalence include aging populations, environmental exposures, lifestyle changes, and improved detection methods. Alpha emitters are utilized in cancer treatment to target and destroy tumor cells with high precision, while minimizing harm to surrounding healthy tissues. For example, in August 2023, the Australian Institute of Health and Welfare, an Australian government health administration, projected that the number of Americans diagnosed with cancer (excluding basal cell carcinomas and squamous cell carcinomas of the skin) will rise from 151,000 in 2021 to 185,000 by 2030. Consequently, the increasing prevalence of cancer is fueling the growth of the alpha emitter market.

Major companies in the alpha-emitter market are focusing on investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to gain a competitive edge. These radionuclides are radioactive isotopes that emit alpha particles during decay and are created by accelerating charged particles to high energies in a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable as the first in the U.S. dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. The production was made possible by commissioning a 30 MeV cyclotron, designed to accelerate alpha particles for the high-yield production of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. This acquisition allows Bristol-Myers Squibb to enhance its oncology portfolio by integrating innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio, Inc. is a US-based provider specializing in alpha emitters.

Major companies operating in the alpha emitter market are Cardinal Health Inc., Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, Blue Earth Diagnostics Ltd., International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, ARTbio AS, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, Convergent Therapeutics, TAE Life Sciences, ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH, Fusion Pharmaceuticals Inc.

North America was the largest region in the alpha emitter market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
• 2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
• 3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
• 4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
• Subsegments:
• 1) By Radium: Radium-223; Radium-226; Radium-228
• 2) By Actinium: Actinium-227; Actinium-225
• 3) By Lead: Lead-210; Lead-212
• 4) By Bismuth: Bismuth-213; Bismuth-212
• 5) By Other Types of Radionuclides: Thorium; Polonium; Francium
• Companies Mentioned: Cardinal Health Inc.; Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alpha Emitter Market Characteristics

3. Alpha Emitter Market Trends And Strategies

4. Alpha Emitter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Alpha Emitter Growth Analysis And Strategic Analysis Framework

• 5.1. Global Alpha Emitter PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Alpha Emitter Market Growth Rate Analysis
• 5.4. Global Alpha Emitter Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Alpha Emitter Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Alpha Emitter Total Addressable Market (TAM)

6. Alpha Emitter Market Segmentation

• 6.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radium
• Actinium
• Lead
• Bismuth
• Other Types Of Radionuclides
• 6.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Sources
• Artificially Produced Sources
• Other Sources
• 6.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pancreatic Cancer
• Ovarian Cancer
• Prostate Cancer
• Lymphoma
• Melanoma
• Bone Metastasis
• Other Applications
• 6.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Medical Research Institutions
• Other End-Users
• 6.5. Global Alpha Emitter Market, Sub-Segmentation Of Radium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radium-223
• Radium-226
• Radium-228
• 6.6. Global Alpha Emitter Market, Sub-Segmentation Of Actinium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Actinium-227
• Actinium-225
• 6.7. Global Alpha Emitter Market, Sub-Segmentation Of Lead, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lead-210
• Lead-212
• 6.8. Global Alpha Emitter Market, Sub-Segmentation Of Bismuth, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bismuth-213
• Bismuth-212
• 6.9. Global Alpha Emitter Market, Sub-Segmentation Of Other Types of Radionuclides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thorium
• Polonium
• Francium

7. Alpha Emitter Market Regional And Country Analysis

• 7.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alpha Emitter Market

• 8.1. Asia-Pacific Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alpha Emitter Market

• 9.1. China Alpha Emitter Market Overview
• 9.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alpha Emitter Market

• 10.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alpha Emitter Market

• 11.1. Japan Alpha Emitter Market Overview
• 11.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alpha Emitter Market

• 12.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alpha Emitter Market

• 13.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alpha Emitter Market

• 14.1. South Korea Alpha Emitter Market Overview
• 14.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alpha Emitter Market

• 15.1. Western Europe Alpha Emitter Market Overview
• 15.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alpha Emitter Market

• 16.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alpha Emitter Market

• 17.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alpha Emitter Market

• 18.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alpha Emitter Market

• 19.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alpha Emitter Market

• 20.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alpha Emitter Market

• 21.1. Eastern Europe Alpha Emitter Market Overview
• 21.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alpha Emitter Market

• 22.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alpha Emitter Market

• 23.1. North America Alpha Emitter Market Overview
• 23.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alpha Emitter Market

• 24.1. USA Alpha Emitter Market Overview
• 24.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alpha Emitter Market

• 25.1. Canada Alpha Emitter Market Overview
• 25.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alpha Emitter Market

• 26.1. South America Alpha Emitter Market Overview
• 26.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alpha Emitter Market

• 27.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alpha Emitter Market

• 28.1. Middle East Alpha Emitter Market Overview
• 28.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alpha Emitter Market

• 29.1. Africa Alpha Emitter Market Overview
• 29.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alpha Emitter Market Competitive Landscape And Company Profiles

• 30.1. Alpha Emitter Market Competitive Landscape
• 30.2. Alpha Emitter Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Alpha Emitter Market Other Major And Innovative Companies

• 31.1. Telix Pharmaceuticals Limited
• 31.2. NorthStar Medical Radioisotopes LLC
• 31.3. ITM Isotope Technologies Munich SE
• 31.4. Blue Earth Diagnostics Ltd.
• 31.5. International Isotopes Inc.
• 31.6. IBA Radiopharma Solutions
• 31.7. Orano Med LLC
• 31.8. ARTbio AS
• 31.9. Actinium Pharmaceuticals Inc.
• 31.10. Clarity Pharmaceuticals Ltd.
• 31.11. RadioMedix Inc.
• 31.12. Nordic Nanovector ASA
• 31.13. Convergent Therapeutics
• 31.14. TAE Life Sciences
• 31.15. ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

32. Global Alpha Emitter Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alpha Emitter Market

34. Recent Developments In The Alpha Emitter Market

35. Alpha Emitter Market High Potential Countries, Segments and Strategies

• 35.1 Alpha Emitter Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Alpha Emitter Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Alpha Emitter Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer